News
-
-
-
COMMUNIQUÉ DE PRESSE
mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development
mAbxience and HP collaborate on AI solution to optimize biomanufacturing and biosimilar development, enhancing predictability and efficiency. Project aims to improve patient access to biologic therapies